I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert whose extensive experience in research, development, and innovation has positioned him as a thought leader in the cell and gene therapy (CGT) industry. With a sharp focus on emerging technologies and strategic growth, Ivan
The pharmaceutical industry stands at a transformative crossroads, where the rapid evolution of biotechnology equipment is poised to redefine the landscape of research and development over the next few years. With projections estimating the global biotech equipment market to surge from $95.1
In the intricate world of cancer biology, the acidic environment within tumors, commonly known as acidosis, stands out as a formidable force that not only challenges cancer cells but also fuels their survival and growth, particularly in aggressive types like pancreatic cancer. Groundbreaking
Today, we’re thrilled to sit down with Ivan Kairatov, a renowned biopharma expert with extensive experience in research, development, and innovation within the biotechnology industry. With a deep understanding of the latest technologies and trends, Ivan offers invaluable insights into the world of
In an era where global health challenges demand unprecedented innovation, artificial intelligence (AI) stands as a beacon of hope for the life sciences industry, with 75% of CEOs prioritizing it as a top investment area according to recent industry surveys. This staggering statistic underscores a
The realm of cell and gene therapies (CGTs) has long been heralded as a revolutionary frontier in medicine, promising transformative outcomes for patients with previously untreatable conditions, yet it faces significant hurdles in securing consistent funding. As the industry matures, it confronts a
